facebook

twitter

youtube

linkedin

Home - News and Events - News - European Medicines Agency (EMA) in Amsterdam

November 16 2017

European Medicines Agency (EMA) in Amsterdam

SHARE

téléchargement

It was announced on November 20^th, 2017 that the European Medicines Agency (EMA) will relocate to Amsterdam. This agency plays a crucial role in the development and authorization of orphan medicines in Europe. Orphan medicines are medicinal products intended for the diagnosis, prevention or treatment of rare diseases. Wishing them all the best in their new home!

Read the official press release here

Vascular Tumors

Revision of Rare Vascular Tumors in the Orphanet Database

d46a568a-3854-4266-9b70-537fc0c9a7c5

Highlights from the International Children Camp 2024 for Primary Lymphedema

Innovative-Therapies-and-Personalised-Medicine-for-Rare-Diseases

Discover the Latest Innovations in Rare Diseases Treatment with this Free Online Course

The European Joint Programme on Rare Diseases building the rare diseases research ecosystem

Celebrating Five Years of Progress with the European Joint Programme on Rare Diseases (EJP RD)

pexels-yankrukov-8613062

New Infographic and Coloring Book for Children with Lymphedema

HHT_EUROPE_1080x1080px-2_page-0001-1-1024x1024-1

Hereditary Hemorrhagic Telangiectasia (HHT) Awareness Month

Rare Barometer Survey Webinar

New Survey on the Impact of Rare Diseases: Launching July 10th, 2024

ERICA 4th General Assembly

ERICA 4th General Assembly & ERN Research Conference in Udine, Italy

End-user Training for the EJP RD Virtual Platform

Join the EJP RD End-user Training Webinar on June 26, 2024!